Bora Pharmaceuticals’ Bobby Sheng Wins ‘CEO of the Year’ at the CPhI Pharma Awards

October 15, 2020
Pharmaceutical Technology Editors

The judges chose Sheng from a shortlist of seven candidates and highlighted his work in the Taiwanese and global markets while guiding the company through “pivotal changes” that demonstrated his abilities as a “top CEO.”

Bora Pharmaceuticals, a contract development and manufacturing organization, announced on Oct. 15, 2020 that its chairman and CEO, Bobby Sheng, was named ‘CEO of the Year’ at the CPhI Pharma Awards 2020.

The award is presented to a C-suite executive who demonstrates leadership skills to drive forward their organization, increase performance, and engage staff and customers, while remaining committed to the development of the pharma industry, a company press release said. The judges chose Sheng from a shortlist of seven candidates and highlighted his work in the Taiwanese and global markets while guiding the company through “pivotal changes” that demonstrated his abilities as a “top CEO.”

Throughout 2020, Sheng headed the expansion of Bora Pharmaceuticals from Asia into the United States and helped the company meet its international growth goals despite the ongoing COVID-19 pandemic, the press release said.

“Winning such a prestigious award is an incredible acknowledgement not just of me, but of the work, values, and expertise of the whole team at Bora Pharmaceuticals,” Sheng said in the press release. “I am incredibly proud of the growth we have achieved thanks to the excellent customer service, technical agility, and niche capabilities that the team at Bora provide to our customers across North America, Asia, and Europe.”

Source: Bora